Hyglos is Profos

Profos AG has been acquired by private investors

19-Mar-2009 - Germany
The former biotech company Profos AG situated in the Biopark in Regensburg has been acquired by new investors and starts from March 2009 as a new company Hyglos GmbH. The new holders of the company are investors coming from science and industry (Hyglos Invest GmbH and bioMérieux S.A.). The focus of Hyglos GmbH is the production and distribution of products and services developed within the last years on the basis of the patented phage-protein technology. Several projects have achieved production level and additionally to the established product portfolio with the main segments “EndoLine” and “Food Diagnostics” further product launches are planned.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances